Stock Market News for October 26, 2026

At a glance

On October 26, 2026, Meta Platforms launched concurrent stock offerings totaling approximately $35 billion; EQT agreed to acquire Range Resources in an all-stock merger exchanging 0.987 EQT shares per Range share; Intel agreed to acquire Classiq with closing expected in H1 2027; Celestica reported Q3 revenue of $5.83 billion and raised its 2026 outlook.

Financings and offerings

Meta Platforms (META) launched concurrent stock offerings totaling approximately $35 billion, comprising $22.5 billion of Class A common stock via forward sale agreements and depositary shares representing about $12.5 billion of mandatory convertible preferred stock.

Deals and acquisitions

EQT (EQT) agreed to acquire Range Resources in an all-stock merger exchanging 0.987 EQT shares per Range share, with existing EQT shareholders to own ~73% of the combined company and closing expected in Q1 2027.

Intel (INTC) entered into a definitive agreement to acquire Classiq, aiming to create a full-stack quantum computing platform; the transaction is expected to close in the first half of 2027, subject to regulatory approvals and customary conditions.

AudioEye (AEYE) reported record third quarter results with third-quarter 2026 net income of $990,000, revenue of $11.0 million and raised full-year adjusted EBITDA guidance to $13.4 million.

RadNet (RDNT) signed a definitive agreement to acquire ONRAD, with ONRAD shareholders to receive $350 million in cash and 5 million RadNet shares at closing, plus an earnout worth up to $210 million contingent on 2027 EBITDA targets; closing expected in early 2027.

Bending Spoons (BSP) completed the acquisition of Miro in an all-cash transaction and said certain former Miro shareholders invested approximately $295 million of their proceeds in about 6.2 million newly issued Bending Spoons ordinary shares via a private placement.

Ovintiv (OVV) agreed to acquire Logan Energy Corp. in an all-cash transaction valued at approximately $890 million including expected closing net debt, with closing expected early in Q1 2027 subject to approvals.

Surgery Partners (SGRY) agreed to be acquired by HealthSpan Partners in an all-cash transaction valuing the company at approximately $5.7 billion enterprise value, with shareholders (excluding Bain affiliates) to receive $23.50 per share; closing expected in Q1 2027.

Earnings and guidance

Celestica (CLS) announced third quarter 2026 financial results reporting Q3 revenue of $5.83 billion, an 83% year-over-year increase, GAAP diluted EPS of $3.26 and raised 2026 revenue guidance to $21.0 billion and adjusted EPS to $11.55.

Verizon Communications (VZ) reported third quarter 2026 results with revenue of $34.3 billion, net income of $5.3 billion and postpaid phone net additions of 406,000, and raised its full-year 2026 outlook to 1.1–1.2 million postpaid phone net additions and adjusted EPS of $5.04–$5.06.

Nucor (NUE) reported third quarter 2026 results with net earnings attributable to stockholders of $1.32 billion and diluted EPS of $5.80 on net sales of $11,249 million for the quarter.

Cadence Design Systems (CDNS) reported third quarter 2026 financial results with revenue of $1.633 billion, 22% year-over-year growth, non-GAAP diluted EPS of $2.11 and raised its full-year revenue growth and adjusted earnings outlook.

Rambus (RMBS) reported third quarter 2026 financial results with Q3 revenue of $218.3 million, up 22% year over year, GAAP diluted EPS of $0.69 and record operating cash flow of $102.5 million.

Amkor Technology (AMKR) reported third quarter 2026 results with sales of $1.991 billion, net income of $191 million, diluted EPS of $0.76 and Q4 2026 guidance of $1.9–$2.0 billion in sales and gross margin of 18.0%–19.0%.

Welltower (WELL) reported third quarter 2026 results with normalized FFO of $1.67 per diluted share (up 24.6% year over year) and raised its 2026 normalized FFO outlook to $6.47–$6.53 per diluted share.

Agilysys (AGYS) reported fiscal 2027 second quarter results with record Q2 revenue of $93.4 million, recurring revenue of $62.2 million and adjusted EBITDA of $24.1 million, and raised full-year revenue and profitability outlook.

Public Storage (PSA) reported third quarter 2026 results with Core FFO of $4.34 per share, raised full-year Core FFO guidance to $16.90–$17.10, and noted completion of the National Storage Affiliates all-stock acquisition and the ~$1.2 billion Public Storage Canada acquisition.

Drug trials and approvals

Oruka Therapeutics (ORKA) announced positive Week 16 results from the EVERLAST-B Phase 2b psoriasis trial, with the 600 mg ORKA-001 group achieving 61% complete skin clearance (PASI 100) at Week 16 versus 0% for placebo (p<0.0001) and PASI 90 and IGA 0/1 rates of 86%.

Mirum Pharmaceuticals (MIRM) reported positive PROGRESS Cohort 2 results for ATEBRIOZ in children aged 6 to <12 with FOP, showing mean heterotopic ossification lesion volume fell 8.09 cm³ with zilurgisertib versus a 9.14 cm³ increase with placebo at Week 24 (nominal p=0.003).

BioNTech (BNTX) announced topline Phase 3 results from DYNASTY-Breast02 showing trastuzumab pamirtecan met the primary endpoint with a statistically significant improvement in progression-free survival versus investigator-selected chemotherapy in HR+/HER2-low metastatic breast cancer; overall survival data were immature at interim analysis.